We hypothesize that elevated AIP, indicative of dyslipidemia marked by elevated TG and reduced HDL-C levels, may contribute to cognitive impairment by promoting inflammation, oxidative stress, and vascular damage, all of which are increasingly recognized as central mechanisms in the pathogenesis of cognitive impairment. Here, AIP is linked to metabolic syndrome.